RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CDTX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for Cidara Therapeutics as stock downgraded to Sell Candidate.
(Updated on Jun 18, 2024)

Sell candidate since Jun 18, 2024 PDF

The Cidara Therapeutics stock price fell by -3.89% on the last day (Tuesday, 18th Jun 2024) from $12.59 to $12.10. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 7.42% from a day low at $11.94 to a day high of $12.82. The price has been going up and down for this period, and there has been a -1.94% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 thousand shares and in total, 40 thousand shares were bought and sold for approximately $486.57 thousand.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $10.85 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 32X during the next 3 months and, with a 90% probability hold a price between $353.83 and $561.79 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CDTX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cidara Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $13.38 and $12.56. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, June 12, 2024, and so far it has fallen -15.80%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Cidara Therapeutics stock

Cidara Therapeutics finds support from accumulated volume at $11.98 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.89 between high and low, or 7.42%. For the last week the stock has had daily average volatility of 5.92%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CDTX) For The Upcoming Trading Day Of Thursday 20th

For the upcoming trading day on Thursday, 20th we expect Cidara Therapeutics to open at $12.29, and during the day (based on 14 day Average True Range), to move between $11.17 and $13.03, which gives a possible trading interval of +/-$0.93 (+/-7.65%) up or down from last closing price. If Cidara Therapeutics takes out the full calculated possible swing range there will be an estimated 15.31% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $11.98 (0.99%) than the resistance at $12.34 (1.98%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cidara Therapeutics stock A Buy?

The Cidara Therapeutics stock holds several negative signals and despite the positive trend, we believe Cidara Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -4.911 Sell Candidate Downgraded

Predicted Opening Price for Cidara Therapeutics of Thursday, June 20, 2024

Fair opening price June 20, 2024 Current price
$12.29 ( 1.53%) $12.10

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CDTX

Fibonacci Support & Resistance Levels

Level Price
R3 13.17 8.84%
R2 12.83 6.05%
R1 12.62 4.32%
Price 12.10
S1 11.95 -1.27%
S2 11.74 -2.99%
S3 11.40 -5.79%

Accumulated Volume Support & Resistance Levels

Level Price
R3 13.00 7.44%
R2 12.63 4.38%
R1 12.34 1.98%
Price 12.10
S1 11.98 -0.99%
S2 11.92 -1.49%
S3 11.81 -2.40%

FAQ

What is the symbol for Cidara Therapeutics Stock and on which exchange is it traded?
The symbol for Cidara Therapeutics is CDTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cidara Therapeutics Stock?
The Cidara Therapeutics stock holds several negative signals and despite the positive trend, we believe Cidara Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy Cidara Therapeutics Stock?
Cidara Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cidara Therapeutics Stock.

What's the current price of Cidara Therapeutics Stock?
As of the end of day on the Jun 18, 2024, the price of an Cidara Therapeutics (CDTX) share was $12.10.

What is the 52-week high and low for Cidara Therapeutics Stock?
The 52-week high for Cidara Therapeutics Stock is $14.96 and the 52-week low is $0.500.

What is the market capitalization of Cidara Therapeutics Stock?
As of the Jun 18, 2024, the market capitalization of Cidara Therapeutics is 55.197M.

When is the next earnings date for Cidara Therapeutics?
The upcoming earnings date for Cidara Therapeutics is Aug 01, 2024.
Click to get the best stock tips daily for free!

About Cidara Therapeutics

Cidara Therapeutics Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive... CDTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT